Cooling Device for CIPN Prevention
Prevention of Chemotherapy-Induced Peripheral Neuropathy
Pre-clinicalActive
Key Facts
Indication
Prevention of Chemotherapy-Induced Peripheral Neuropathy
Phase
Pre-clinical
Status
Active
Company
About Eisana
Eisana Health is a private, pre-revenue biotech startup founded in 2020, targeting a critical unmet need in oncology supportive care. The company is developing a novel, patient-centric cooling device aimed at preventing nerve damage caused by common chemotherapy agents, a condition known as CIPN which currently lacks a cure. By focusing on a home-use device, Eisana aims to improve accessibility and adherence to preventive measures. Its success hinges on clinical validation, market adoption, and navigating a competitive landscape of both established and emerging cooling technologies.
View full company profile